A
-
Abdelzaher, Arafat
FORMULATION AND CHARACTERIZATION OF THERMOSENSITIVE CHITOSAN HYDROGEL LOADED WITH ERLOTINIB: FULL FACTORIAL DESIGN OF RELEASE DATA [Volume 68, Issue 2, 2023, Pages 1-27]
-
Abo-Senna, Amal S
MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]
-
Abuelghait, Mohamed
CORRELATION BETWEEN BIOFILM OF DENTAL MICROBES AND ANTIBIOTIC RESISTANCE, IN VITRO STUDY [Volume 68, Issue 2, 2023, Pages 188-205]
-
Afouna, Mohsen M
PREPARATION AND CHARACTERIZATION OF ATROPINE SULFATE ORODISPERSIBLE TABLETS [Volume 68, Issue 2, 2023, Pages 43-63]
-
Ahmed, Ahmed Mohamed Ahmed
DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR SIMULTANEOUS DETERMINATION OF PYRIMETHAMINE AND SULFADOXINE IN THE PHARMACEUTICAL PREPARATION [Volume 68, Issue 2, 2023, Pages 159-171]
-
Alhalafwy, Asmaa
CORRELATION BETWEEN BIOFILM OF DENTAL MICROBES AND ANTIBIOTIC RESISTANCE, IN VITRO STUDY [Volume 68, Issue 2, 2023, Pages 188-205]
-
Aref, Mostafa Mohammed
AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS [Volume 68, Issue 2, 2023, Pages 130-158]
-
Ayyad, Rezk R
VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [Volume 68, Issue 2, 2023, Pages 111-129]
D
-
Dahab, Mohammed A
AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS [Volume 68, Issue 2, 2023, Pages 130-158]
E
-
Eissa, Ibrahim H
PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 64-81]
-
El-Olemy, Ahmed
DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR SIMULTANEOUS DETERMINATION OF PYRIMETHAMINE AND SULFADOXINE IN THE PHARMACEUTICAL PREPARATION [Volume 68, Issue 2, 2023, Pages 159-171]
-
Elwan, Alaa
PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 64-81]
-
Elwan, Alaa
VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [Volume 68, Issue 2, 2023, Pages 111-129]
-
El-Zahabi, Mohamed Ayman ALy
PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 64-81]
-
El-Zahabi, Mohamed Ayman ALy
EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 82-110]
-
El-Zahabi, Mohamed Ayman ALy
AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS [Volume 68, Issue 2, 2023, Pages 130-158]
-
Emam, Mohamed H
PREPARATION AND CHARACTERIZATION OF ATROPINE SULFATE ORODISPERSIBLE TABLETS [Volume 68, Issue 2, 2023, Pages 43-63]
-
Emara, Mohamed S
DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR SIMULTANEOUS DETERMINATION OF PYRIMETHAMINE AND SULFADOXINE IN THE PHARMACEUTICAL PREPARATION [Volume 68, Issue 2, 2023, Pages 159-171]
G
-
Gebreel, Hassan M
CORRELATION BETWEEN BIOFILM OF DENTAL MICROBES AND ANTIBIOTIC RESISTANCE, IN VITRO STUDY [Volume 68, Issue 2, 2023, Pages 188-205]
H
-
Hegazy, Dalia N
MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]
-
Hosseny, Ebtesam N
MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]
I
-
Ibrahim, Mohamed F
PREPARATION AND CHARACTERIZATION OF ATROPINE SULFATE ORODISPERSIBLE TABLETS [Volume 68, Issue 2, 2023, Pages 43-63]
K
-
Khodeir, Mohamed H
MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]
M
-
Marzouk, Adel A
EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 82-110]
-
Mohamed, Abeer A
AN OVERVIEW OF QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS [Volume 68, Issue 2, 2023, Pages 130-158]
-
Mohammed, Ahmed
FORMULATION AND CHARACTERIZATION OF THERMOSENSITIVE CHITOSAN HYDROGEL LOADED WITH ERLOTINIB: FULL FACTORIAL DESIGN OF RELEASE DATA [Volume 68, Issue 2, 2023, Pages 1-27]
-
Mohammed, Ahmed
FORMULATION AND CHARACTERIZATION OF DIFFERENT TOPICAL HYDROGELS LOADED WITH SILDENAFIL CITRATE [Volume 68, Issue 2, 2023, Pages 28-42]
-
Mowafy, Hammam A
PREPARATION AND CHARACTERIZATION OF ATROPINE SULFATE ORODISPERSIBLE TABLETS [Volume 68, Issue 2, 2023, Pages 43-63]
N
-
Nassar, Mohamed W
DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR SIMULTANEOUS DETERMINATION OF PYRIMETHAMINE AND SULFADOXINE IN THE PHARMACEUTICAL PREPARATION [Volume 68, Issue 2, 2023, Pages 159-171]
O
-
Osman, Shaaban K.
FORMULATION AND CHARACTERIZATION OF THERMOSENSITIVE CHITOSAN HYDROGEL LOADED WITH ERLOTINIB: FULL FACTORIAL DESIGN OF RELEASE DATA [Volume 68, Issue 2, 2023, Pages 1-27]
-
Osman, Shaaban K.
FORMULATION AND CHARACTERIZATION OF DIFFERENT TOPICAL HYDROGELS LOADED WITH SILDENAFIL CITRATE [Volume 68, Issue 2, 2023, Pages 28-42]
-
Otify, Islam
VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [Volume 68, Issue 2, 2023, Pages 111-129]
-
Ouf, Abdelsalam Mohamed
EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 82-110]
S
-
Sakr, Helmy
VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [Volume 68, Issue 2, 2023, Pages 111-129]
-
Salem, Zeinab T
MONITORING OF RABIES IMMUNE STATUS IN EXPERIMENTALLY VACCINATED PUPPIES [Volume 68, Issue 2, 2023, Pages 172-187]
-
Shykhoon, Montaser A
EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 82-110]
Y
-
Yaseen, Abobakr
FORMULATION AND CHARACTERIZATION OF DIFFERENT TOPICAL HYDROGELS LOADED WITH SILDENAFIL CITRATE [Volume 68, Issue 2, 2023, Pages 28-42]
-
Yousef, Reda G
PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS [Volume 68, Issue 2, 2023, Pages 64-81]
-
Youssef, HebatAllah Ibrahim
CORRELATION BETWEEN BIOFILM OF DENTAL MICROBES AND ANTIBIOTIC RESISTANCE, IN VITRO STUDY [Volume 68, Issue 2, 2023, Pages 188-205]
Your query does not match with any item